Abstract The aim of this study is to investigate the role and mechanism of microglial NOX2 activation in minimally toxic dose of LPS and Syn-elicited synergistic dopaminergic neurodegeneration. NOX2
Introduction
In Parkinson disease (PD), the conspicuous loss of dopaminergic neurons has already occurred by the time of clinical presentation, which etiology and pathogenesis are not fully understood yet. Currently, it is generally accepted that PD is propagated by the complex interplay of multiple factors, including environmental factors, aging, and genetic predisposition, in which environmental exposures greatly increase the risk of developing PD. A body of environmental factors has been demonstrated to contribute to the development of PD [1] ; however, neither is believed to be independently sufficient to induce PD.
More recently, neuroinflammation featured by microglial activation has been implicated as an engine driving the progressive loss of dopaminergic neurons [1] . Microglia reside in the brain, comprise approximately 12% of total cell, and serve as the immune defense of the brain [2] . At resting state, microglia are protective for the brain through surveillance of environment and removal of cell debris. However, microglia can be activated by a variety of stimuli after exposure to pathological conditions [3] .
There are more microglia with higher activity in substantia nigra (SN) comparing with other brain regions, which determines that microglia in SN are readily activated by an extensive list of exogenous environmental stimuli, such as diesel exhaust particles [4] , paraquat [5] , and rotenone [6] and cause deleterious effect on dopaminergic neurons. Remarkably, lipopolysaccharide (LPS), a cell wall component of gram-negative bacteria, is a very potent exogenous stimulus of microglial immune response. Mounting evidences display that LPS activates microglia and produces a line of neuroinflammatory factors in both animal and human, propagating cumulative loss of dopaminergic neurons with time extending [7] [8] [9] . Accordingly, LPS-elicited neuroinflammation and subsequent dopaminergic neurodegeneration is relevant to PD. Additionally, a variety of endogenous factors, such as neuromelanin [10] , 6-hydroxydopamine [11] , matrix metalloproteinase-3 [12] , μ-calpain [13] , are toxic to dopaminergic neurons through microglial activation. α-Synuclein (Syn) is the major protein component of Lewy bodies (LB), the pathological hallmark of PD, in dopaminergic neurons. However, investigators observe excessive toxic oligomer Syn in the extracellular space, which may be attributed to its enhanced release driven by environmental factors as well as neurodegeneration [14] [15] [16] . Our previous works have demonstrated that both aggregated [17] and mutant Syn isoforms [18] in the extracellular space propagate the sustained dopaminergic degeneration via surrounding microglial activation.
However, it is too late to investigate the neurodegenerative mechanisms when dopaminergic neurons are excessively exposed to above environmental factors. Thus, we ask an array of questions: Does exposure to exogenous factor (LPS) and endogenous factor (Syn) with minimally toxic dose synergistically elicit progressive dopaminergic neurodegeneration? Do glia surrounding dopaminergic neurons in SN play a role in dopaminergic neurodegenerative process? Are microglia or astroglia contributable to the synergistic dopaminergic neurodegeneration? What are the underlying mechanisms of glial activation? Less is known about these issues yet.
In this study, we explored the role of minimally toxic dose of LPS and Syn on dopaminergic neurodegeneration both in vivo and in vitro and investigated the potential mechanisms of microglial activation by using multiple well-established primary midbrain cultures [19] , in which we especially focused on the critical role of microglial β-nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2), a superoxide (O 2 ·− )-generating enzyme, by using NOX2 knockout (NOX2 −/− ) mice and a NOX2 inhibitor, and relevant signaling molecules of NOX2 activation.
Methods

Reagent
Materials relating cell cultures were from Invitrogen (Carlsbad, CA, USA). [ 3 H] dopamine (DA) (28 Ci/mmol) and [ 3 H] gamma-aminobutyric acid (GABA) (81 Ci/mmol) were from PerkinElmer Life Science (Boston, MA, USA). Polyclonal anti-tyrosine hydroxylase (TH), anticomplement receptors 3 (OX-42), anti-neuron-specific nuclear protein (Neu N), anti-protein kinase C-σ (PKC-σ), anti-P38, anti-extracellular signal-regulated kinase1/2 (ERK1/2), anti-c-Jun N-terminal kinase (JNK), and antinuclear factor-КB P50 (NF-КB P50 ) antibodies were from R&D Systems (Minneapolis, MN, USA). Anti-ionized calcium binding adaptor molecule-1 (Iba-1) antibody was from Abcam (330 Cambridge Science Park, Cambridge, UK). Vectastain ABC kit and biotinylated secondary antibodies were from Vector Laboratories (Burlingame, CA, USA). Fluorescence probe 2′,7′ -dichlorodihydrofluorescein (DCFH-DA), cytosine arabinoside (Ara-C), Leu-Leu methyl ester hydrobromedia (LME), superoxide dismutase (SOD), 2-(4 lodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazo1ium (WST-1), and diphenyleneiodonium (DPI) were from Sigma-Aldrich (St. Louis, MO, USA). SYBR green PCR master mix was from Applied Biosystems (Foster City, CA, USA).
Animals
SD rats were from Peking Vital River Laboratory and Centre of Experimental Animal of Peking University. C57 BL/6J (NOX2 wild type, NOX2 +/+ ) and NOX2 −/− mice were from Jackson Laboratories (Bar Harbor, Maine, USA). Breeding schedules were designed to achieve accurately timed pregnancy of 14 ± 0.5 days for rats and 13 ± 0.5 days for mice. Housing, breeding, and experimental use of the animals were performed in strict accordance with the National Institutes of Health guidelines.
Primary Midbrain Neuron-Glia (Neuron-Microglia-Astroglia) Cultures
Primary midbrain neuron-glia cultures were prepared from the brains of embryonic day 14 ± 0.5 days of SD rats and 13 ± 0.5 days of NOX2 +/+ and NOX2 −/− mice. Ventral midbrain tissues were removed and dissociated. Cells were seeded at culture plate precoated with poly-D-lysine and maintained at 37°C incubator with humidified atmosphere of 5% CO2 and 95% air. Seven-day cultures were used for treatment. The composition of the cultures included about 48% astroglia, 11% microglia, and 40% neurons, of which 2-3% was THimmunoreactive (TH-ir) dopaminergic neurons (see Supplemental Material, p. 1).
Primary Midbrain Neuron-Enriched Cultures
Rat primary midbrain neuron-enriched cultures, with a purity of >95%, were established as described previously [17] . Briefly, 1 day after seeding neuron-glia cultures, Ara-C was added to at a final concentration of 7.5 μM to suppress glial proliferation, and 3 days later, cultures were changed back to maintenance medium. Seven days after initial seeding, cultures were used for treatment.
Primary Midbrain Neuron-Astroglia Cultures (Microglia-Depleted Cultures)
Primary midbrain neuron-astroglia cultures, with 54% astroglia, 1% microglia, and 45% neurons, were established as described previously [17] . Briefly, 1 day after seeding neuron-glia cultures, LME was added at a final concentration of 1.5 mM to suppress microglia proliferation, and 3 days later, cultures were changed back to maintenance medium. Seven days after initial seeding, cultures were used for treatment.
Primary Mixed Glia Cultures, Microglia Cultures, and Astroglia cultures Whole brain tissues of 1-day-old pups from SD rats, NOX2
+/+ and NOX2 −/− mice were triturated after removing the meninges and blood vessels. Cells were seeded in a 150 cm 2 culture flask. After a confluent monolayer of primary glia cultures was obtained, microglia were shaken off and seeded in culture plate. After at least 4 separations of microglia, astroglia were detached with trypsin-EDTA and seeded in the same culture medium as that used for microglia (see Supplemental Material, p. 2). /well) of astroglia back to neuron-enriched cultures 1 day before treatment [17] .
Treatment
Minimally toxic dose of Syn or LPS produces minor damage to dopaminergic neurons functionally and morphologically, which is not statistically significant compared with normal control.
In our previous study, commercially purified Syn was aged in PBS at 37°C for 0-14 days. Remarkably, at day 7 of aging, most Syn aggregates were oligomers detected by Western blot and electron microscopic examination [17] . We found that the minimally toxic dose of Syn was 20 nmol/L. LPS was freshly prepared as a stock solution with PBS and diluted to the minimally toxic dose of 0.5 ng/mL in the treatment medium based on our previous work. Multiple cultures were treated with LPS (0.5 ng/mL) and/or Syn (20 nmol/L) in a final volume of 1 mL/well for 8 days. 
Neurotoxicity Measurement by [
Immunostainings
Primary midbrain neuron-glia cultures exposed with LPS and/ or Syn for 8 days were fixed with 3.7% formaldehyde, treated with 1% hydrogen peroxide followed by sequential incubation with blocking solution, related primary antibodies, biotinylated secondary antibodies, and ABC reagents. Color was developed and images were recorded. TH-ir dopaminergic neurons in a well, Neu N-ir total neurons, and OX-42-ir microglia in nine representative areas per well were visualized under microscope at ×100 magnification (see Supplemental Material, p. 2). 
iROS Assay
Primary microglia cultures were seeded for 1 day, washed for 2 times with HBSS, incubated with DCFH-DA for 2 h at 37°C and finally treated with vehicle, LPS, and/or Syn. Fluorescence intensity was measured at 485 nm for excitation and 530 nm for emission. iROS level was measured by the increased absorbance in 2 h and expressed as the percentage of control group (see Supplemental Material, p. 3).
RT and Real-Time PCR mRNA levels of microglial NOX2 subunits P47and gp91, PKC-σ, P38, ERK1/2, JNK, and NF-КB P50 after LPS and/or Syn treatment were detected by RT and real-time PCR, which sequences of forward and reverse primers were as follows:
Total RNA was isolated with Trizol reagent, followed by purification, reversed transcription, and real-time PCR analysis. Relative differences in expressions between groups were determined by cycle time (Ct) values as follows: Ct values for the genes of interest were first normalized with β-actin of same sample; then, relative differences between control and LPS and/or Syn-treated groups were calculated and expressed as the percentage of control. Standard curve analysis was performed and used for the calculation (see Supplemental Material, p. 4).
Western Blot
Primary microglia cultures treated with LPS and/or Syn were detached by scraping in sampling buffer. NOX2 subunits P47and gp91, PKC-σ, P38, ERK1/2, JNK, and NF-КB P50 were isolated via acid extraction adjusted to equal protein concentrations and separated by 4-12% polyacrylamide-0.1% SDS miningels then were transferred onto a PVDF membrane. Blots were incubated with related primary antibody then probed with a horseradish peroxidase-conjugated secondary antibody. Detection was performed by using ECL kit.
Animal Studies
Eight-week-old NOX2 +/+ and NOX2 −/− mice were kept on a 12-h light/dark cycle with ad libitum access to food and water and acclimated to their environment for 2-4 weeks before use. Mice (25-30 g) received vehicle saline, Syn (0.0125 μg/uL), and/or LPS (0.2 μg/uL). For SNpc injection, mice were deeply anesthetized by chloral hydrate (300 mg/kg, s.c.) then fixed on stereotaxic frame. LPS was injected bilaterally to 0.7 mm anterior from the bregma, 1.0 mm lateral from the midline, and 3.4 mm from the dura. Mice were sacrificed 4 weeks later. Striatal tissues were rapidly dissected, immediately frozen on dry ice, and stored at −80°C until use. The rest of the brain was fixed in 3.7% paraformaldehyde followed by cryoprotection in 30% sucrose before use.
Immunohistochemistry and Cell Counting
Immunohistochemistry and cell counting were conducted as described previously [19] . Briefly, coronal sections (35 μm) covering entire SN and striatum were obtained. After blocking, sections were incubated overnight at 4°C with anti-TH and anti-Iba1 antibodies followed by biotinylated secondary antibody and Vectastain ABC reagents. The first (rostral) and every forth section of 24 sections of each brain from eight animals for each group were counted under microscope at ×100 magnification. Mean value of the numbers of TH-ir dopaminergic neurons and Iba1-ir microglia in SNpc was deduced by averaging the counts of 6 sections for each animal. Results were expressed as the percentage of control group (see Supplemental Material, p5).
Analysis of DA Level in Striatum
DA level in striatum was determined by high-performance liquid chromatography coupled with electrochemical detection as described [20] . Briefly, striatal tissues were sonicated in 0.2 M perchloric acid (20% W/V), containing internal standard 3,4-dihydroxybenzylamine (10 mg wet tissue/mL). The homogenate was centrifuged and 20 μL aliquot of supernatant was injected into HPLC equipped with a 3 μm C 18 column. Mobile phase was comprised of 26 mL of acetonitrile, 21 mL of tetrahydrofuran, and 960 mL of 0.15 M monochloroacetic acid (PH 3.0), containing 50 mg/L of EDTA and 200 mg/L of sodium octyl sulfate. DA level was determined by comparison of peak height ratio of tissue sample with standards and expressed as the percentage of control group.
Statistical Analysis
Three wells were used in each treatment, which was considered as an independent experiment. Standard errors were calculated from three independent experiments. Results were expressed as the mean ± SE. Statistical significance was assessed with an analysis of one-way ANOVA, with the freedom representing the numbers of experiments minus one, followed by Bonferroni's t test using SPSS20.0 software. P < 0.05 was considered statistically significant.
Results
LPS and Syn Synergistically Elicit Dopaminergic Neurotoxicity Through Multiple Manners
Rat primary midbrain neuron-glia cultures were treated with LPS and Syn in three methods: simultaneous treatment with LPS and Syn for 8 days, 4 days of LPS followed by 4 days of Syn, and 4 days of Syn followed by 4 days of LPS. Control, LPS, Syn, and LPS+Syn groups were included in each method. The results indicate that, comparing with either LPS or Syn group, LPS+Syn group synergistically reduces DA uptake and dopaminergic neuronal numbers in above treatment methods (Fig. 1a-c) and causes damage to dopaminergic neurons morphologically indicated by the small cell bodies, reduced cytoplasmic stainings, and shortened dendrites (Fig. 1) .
Synergistic Dopaminergic Neurotoxicity Induced by LPS and Syn Is Selective and Progressive
In rat primary midbrain neuron-glia cultures, comparing with LPS or Syn group, GABA uptake is largely preserved comparing with DA uptake (Fig. 2a) , and Neu N-ir total neurons are mostly saved comparing with TH-ir dopaminergic neurons in LPS+Syn group (Fig. 2b) ; meanwhile, DA uptake and THir dopaminergic neurons in LPS+Syn group are significantly reduced with time extending, in a time-dependent manner (Fig. 2c, d ). 
Microglia Are The Major Players for the Synergistic Dopaminergic Neurotoxicity Elicited by LPS and Syn
Comparing with LPS or Syn group, DA uptake in rat primary neuron-enriched cultures is remarkably spared comparing with that in neuron-glia cultures in LPS+Syn group (Fig. 3a) .
In rat primary midbrain neuron-astroglia cultures by depleting microglia, DA uptake in LPS+Syn group is not different with that in LPS or Syn group (Fig. 3b) . In the reconstituted cultures with 40 and 50% astroglia back to neuron-enriched cultures, DA uptake in LPS+Syn group shows no discrepancy comparing with that in LPS or Syn group (Fig. 3b) .
In rat primary microglia-depleted cultures, DA uptake in LPS+Syn group displays no marked difference comparing with LPS or Syn group (Fig. 3c) . In the reconstituted cultures with 10 and 20% microglia back to neuron-enriched cultures, the more the microglia added, the greater the DA uptake abolished (Fig. 3c) .
LPS and Syn Elicit Progressive Microglial Activation Functionally and Morphologically
In rat primary microglia cultures, extracellular O 2 − and iROS in LPS+Syn group are robustly produced 30 min and 2 h, respectively, comparing with that in LPS or Syn group (Fig. 4a, b) . In rat primary midbrain neuronglia cultures, activated microglia in LPS+Syn group are gradually enhanced with time extending comparing with that in LPS or Syn group (Fig. 4c) . Comparing with LPS or Syn group, microglia in LPS+Syn group are essentially activated morphologically, which is indicated by the enlarged cell bodies, irregular shape, and intensified OX-42 stainings (Fig. 4d) .
NOX2 −/− Mice Are More Resistant to the Synergistic Dopaminergic Neurotoxicity Induced by LPS and Syn Due to the Less Microglial Activation
Nigral dopaminergic neurons and striatal DA in LPS+Syn group in NOX2 +/+ mice are greatly decreased comparing with that in NOX2 −/− mice (Fig. 5a, b) . DA uptake and TH-ir dopaminergic neurons in LPS+Syn group in primary midbrain neuron-glia cultures derived from NOX2 +/+ mice are significantly reduced comparing with that in the cultures derived from NOX2 −/− mice (Fig. 5c,   d ). Comparing with NOX2 −/− mice, the morphologies of dopaminergic neurons in LPS+Syn in primary midbrain neuron-glia cultures in NOX2 +/+ mice are drastically damaged, which is indicated by small cell bodies, reduced cytoplasmic stainings, and decreased, shorter dendrites (Fig. 5e) .
The levels of O 2 ·− and iROS in LPS+Syn group in primary microglia cultures derived from NOX2 +/+ mice are evidently increased 30 min and 2 h later, respectively, comparing with that in the cultures derived from NOX2 −/− mice (Fig. 5f, g ). Results are expressed as a percentage of the vehicle-treated control group and are the mean ± SE from three independent experiments in triplicate. *P < 0.05 and **P < 0.01 for LPS+Syn group vs. LPS or Syn group Activated microglia in LPS+Syn group in substantia nigra and neuron-glia cultures inNOX2 +/+ mice are remarkably enhanced comparing with that in NOX2 −/− mice (Fig. 5h, i ).
Microglia derived from NOX2 +/+ mice in LPS+Syn group are strikingly activated morphologically comparing with that in the cultures derived from NOX2 +/+ mice (Fig. 5j) .
Microglial NOX2 Inhibitor Alleviates Microglial Activation Induced by LPS and Syn and Protects Dopaminergic Neurons
In rat primary midbrain neuron-glia cultures, DA uptake and TH-ir dopaminergic neurons in LPS+Syn group are conspicuously reduced 8 days after treatment comparing with LPS or Syn group. Pretreatment with DPI, a potential NOX2 inhibitor, at 0.01 and 0.1 μM, significantly increases DA uptake and restores dopaminergic neuronal survival (Fig. 6a, b) . 0.1 μM DPI alone shows no significant effect on both DA uptake and dopaminergic neuronal numbers (Fig. 6a, b) . In rat primary microglia cultures, the levels of O 2 ·− and iROS in LPS+Syn group are remarkably enhanced 30 min and 2 h after treatment, respectively. Pretreatment with DPI at 0.01 and 0.1 μM 30 min before treatment with LPS and Syn drastically decreases O 2 ·− level and activated microglial numbers (Fig. 6c, d ). 0.1 μM DPI alone exerts no significant effect on O 2 ·− productions and microglial numbers (Fig. 6c, d ).
Expressions of NOX2 Cytoplasm Subunit P47 and Cell Membrane Subunit gp91 Are Elevated by LPS and Syn
In rat primary microglia cultures, mRNA and protein levels of NOX2 cytoplasm subunit P47 and cell membrane subunit gp91 in LPS+Syn group are observably enhanced 20 and 25 min after treatment, respectively (Fig. 7a-c) .
Expressions of PKC-δ, P38, ERK1/2, JNK, and NF-κB P50 Are Upregulated by LPS and Syn
In rat primary microglia cultures, mRNA and protein levels of PKC-δ at 3 and 5 min (Fig. 8a, b) , P38 (Fig. 8c, d ), ERK1/2 (Fig. 8e, f) and JNK (Fig. 8g, h ) at 10 and 15 min, and NF-κB P65 at 2 and 3 h (Fig. 8i, j) in LPS+Syn group are drastically upregulated comparing with LPS or Syn group.
Discussion
In the current study, we investigated the role of minimally toxic dose of LPS and Syn on dopaminergic neurodegeneration both in vivo and in vitro, and the underlying mechanisms of microglial NOX2 activation and relevant signaling molecules by using knockout mice and inhibitor of NOX2.
Rodent primary midbrain neuron-glia cultures with the composition similar to human is a well-established tool for studying the pathogenesis of dopaminergic neurodegeneration in PD. Function of dopaminergic neuron is assessed by the uptake of neurotransmitter DA and the morphology is evaluated by TH staining. In this study, LPS and Syn synergistically decrease DA uptake and TH-ir dopaminergic neuronal numbers when comparing with LPS or Syn alone, 8 days after treatment in three manners. Morphologically, dopaminergic neuronal bodies are shrunk, cytoplasmic stainings are reduced, and neuronal dendrites are decreased, shortened, broken, and even disappeared. These data indicate that LPS and Syn cause synergistic dopaminergic neurodegeneration both functionally and morphologically. −/− mice were treated with LPS and/or Syn, and the levels of extracellular O 2 ·− (probed with WST-1) (f) and iROS (probed with DCFH-DA) (g) were measured 30 min and 2 h later, respectively. Results are expressed as a percentage of the vehicle-treated control group and are the mean ± SE from three independent experiments in triplicate. *P < 0.05 for LPS+Syn group vs. LPS or Syn group. Representative microscopic images of dopaminergic neurons (TH staining, ×100 magnification) (e) and microglia (OX-42 staining, ×100 magnification) (j) are shown. Scale bar, 100 μm Effects of LPS and Syn on dopaminergic and GABA neurons are compared by measuring uptake capacities of DA and GABA and visualizing the numbers of TH-ir dopaminergic neurons and NeuN-ir total neurons. Although Neu N is a marker of all neurons, it is used for assessing nondopaminergic neurons because dopaminergic neurons merely account for 2 _ 3% of total neurons in SNpc. Data from this study indicate that DA uptake capacity is robustly decreased when comparing with GABA uptake capacity, and dopaminergic neuronal numbers are greatly reduced when comparing with NeuN-ir total neurons, demonstrating that neurodegeneration elicited by LPS and Syn is relatively selective to dopaminergic neurons. Furthermore, DA uptake capacity and dopaminergic neuronal numbers are gradually reduced with time extending, indicating that LPS and Syn induce progressive dopaminergic neurodegeneration.
LPS and Syn induce synergistic dopaminergic neurotoxicity in primary neuron-microglia-astroglia cultures; however, it is not clear whether the neurotoxicity is attributed to their direct effect on dopaminergic neurons or indirect effect via microglial activation. These questions have been answered by using multiple primary cell cultures. Firstly, in primary neuron-enriched cultures, synergistic dopaminergic neurotoxicity is not found after treatment with LPS and Syn, implying Results are expressed as a percentage of the vehicle-treated control group from three independent experiments in triplicate. #P < 0.05 for LPS+Syn group vs. control group,*P < 0.05 and **P < 0.01 for DPI pretreatment groups vs. LPS+Syn group, # P < 0.05 for LPS+Syn group vs. Control group that glial cells, astroglia, or microglia may play a critical role. Secondly, in neuron-astroglia cultures by depleting microglia or in reconstituted cultures with different percentages of astroglia added to neuron-enriched cultures, dopaminergic neurotoxicity is not observed after stimulation with LPS and Syn, indicating that astroglia are not the player in the synergistic dopaminergic neurotoxicity. Finally, treatment with LPS and Syn is not toxic to dopaminergic neurons in microgliadepleted cultures but is dramatically toxic in microgliareconstituted cultures, in a percentage-dependent manner, illucidating that microglia are the contributors for the synergistic dopaminergic neurotoxicity induced by LPS and Syn.
Increasing evidences show that, upon some stimuli, microglia are activated and generate a line of neuroinflammatory factors [17, 18] , which may be relevant to dopaminergic neurotoxicity in PD. However, it has not been investigated how microglia induce synergistic dopaminergic neurotoxicity after treatment with LPS and Syn. Our data show that, upon stimulation with LPS and Syn, microglia generate magnitude of neurotoxic ROS, in which, extracellular O 2 ·− is the factor quickly produced after activation of NOX2, the key O 2 ·− -producing enzyme in brain microglia [21] . O 2 ·− can promote the generation and release of downstream neuroinflammatory factors such as tumor necrosis factor-α [22] and prostaglandin E 2 [17] through formation of hydrogen peroxide [23, 24] . Hence, O 2 ·− generated by microglial NOX2 may be the potential trigger of dopaminergic neurotoxicity mediated by LPS and Syn. Mounting evidences illustrate pivotal role of iROS as a second messenger in the cascade event of neuroinflammation [19] . Multiple sources contribute to the production of iROS, among which, NOX2-generating O 2 ·− account for the most of total iROS [25] . It is demonstrated that iROS initiates the upregulation of NF-КB, which subsequently produces an array of neuroinflammatory factors. Each neuroinflammatory factor may not be sufficient in the degeneration of dopaminergic neurons; however, they may work together and intensify the neurotoxic effect of each other, propagating dopaminergic neurotoxicity (data not shown). Morphologically, microglial are activated by LPS and Syn, which is featured by the enlarged cell bodies, irregular cell shape, intensified OX-42 staining, and increased number with time extending. Thus, microglial activation may be an engine driving the synergistic dopaminergic neurodegeneration during the entire degenerative process.
NOX family is composed of NOX1 _ 5 and dual oxidase 1 _ 2 [22] , among which, NOX2 is mainly distributed in brain regions of the SN, striatum, hippocampus, and cortex [26] . Previous investigations show that, in a LPS in vitro model, microglia derived from NOX2 +/+ mice produce more O 2 ·− and neuroinflammatory factors than that derived from NOX2 −/− mice; thus, it is the activation of NOX2 in micoglia but not in astroglia and neurons that causes toxic effect to dopaminergic neurons [25, 27] . Results from this investigation demonstrate that synergistic dopaminergic neurotoxicity induced by LPS and Syn is indicated by significantly reduced DA uptake mice, implying that microglia are the major sources of NOX2-generated O 2 ·− after stimulation with LPS and Syn. Simultaneously, data from this study indicate that DPI, a potential NOX2 inhibitor, protects against dopaminergic neurodegeneration synergistically provoked by LPS and Syn, which is revealed by the dramatically preserved DA uptake and restored dopaminergic neuron through reducing O 2 ·− generation and activated microglia. Thus, the progressive and selective dopaminergic neurodegeneration synergistically induced by LPS and Syn is microglial NOX2-dependent. What are the potential molecular mechanisms of microglial NOX2 activation elicited by LPS and Syn? P47 and gp91are two critical subunits for NOX2 activation, which are located in cytoplasm and cell membrane separately in resting state [28] . However, P47 translocates to membrane and combines with gp91 when exposed to various stimuli, during which O 2 ·− is produced. In this study, mRNA and protein levels of P47 and gp91 are strikingly upregulated 20 and 25 min after exposure to LPS and Syn, respectively, revealing the significance of microglial NOX2 activation in synergistic dopaminergic neurotoxicity.
PKC, MAPKs, and NF-КB are reported to be the potential signaling pathways relating to neurodegenerative diseases [29] and neuroinflammation [30] . PKC-δ, a member of PKC family, is observed to have a relevance to microglial NOX2 activation in PD [31] . Activity of microglial NOX2 is reduced for more than 90% when expression of PKC-δ is largely inhibited [32] . ROS level is attenuated by GF109203X, a PKC-δ inhibitor in addition to DPI [33] . PKC-δ is found to enhance P47 expression and provoke translocation of P47 from cytoplasm to membrane [31] . Accordingly, PKC-δ may be a potential signaling molecule for microglial NOX2 activation. In this investigation, mRNA and protein levels of PKC-δ are robustly elevated as early as 3 and 5 min after treatment with LPS and Syn, respectively, implying that PKC-δ is the earliest molecule triggering microglial NOX2 activation after stimulation with LPS and Syn. MAPKs include several molecules, including P38, ERK1/2, and JNK, which can be activated by a host of environmental factors [17, 34] and correlated with the elevated expressions of a variety of neuroinflammatory proteins that are highly relevant to microglial NOX2 activation [35] . In this study, both mRNA and protein levels of P38, ERK1/2, and JNK are significantly increased 10 and 15 min, respectively, after stimulation with LPS and Syn, which are prior to that of P47 and gp91, illustrating that MAPKs are the next signaling molecules of microglial NOX2 activation induced by LPS+Syn. NF-КB, a nuclear transcription factor, initiates the generations of series of downstream neuroinflammatory factors [36] . A close relationship between NF-КB and NOX2 has been demonstrated through attenuating NF-КB activation by NOX2 inhibitor [36] . NF-κB has cross talks with MAPKs and PKC [37] . In this investigation, mRNA and protein levels of NF-КB p50 are significantly elevated 2 and 3 h, respectively, after stimulation with LPS and Syn. We speculate that NOX2-generated O 2 ·− by LPS+ Syn enters microglia and elevates iROS level, triggers the upregulation of NF-КB p 5 0 and production of neuroinflammatory factors, and causes the synergistic dopaminergic neurodegeneration.
Conclusion
In brief, results from this investigation elucidate that combination of exogenous and endogenous environmental factors with minimally toxic dose synergistically propagates dopaminergic neurodegeneration through activating microglial NOX2. Thus, PD is the outcome of multiple etiologies through neuroinflammatory mechanism. Inhibition of microglial NOX2 activation elicited by various environmental factors may be a novel target for PD therapy.
